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Summary. The diagnosis of invasive candidiasis remains a clinical challenge. The detection by indirect immunofluorescence 
of Candida albicans germ-tube-specific antibodies (CAGTA), directed against germ-tube surface antigens, is a useful diagnostic 
tool that discriminates between colonization and invasion. However, the standardization of this technique is complicated by its 
reliance on subjective interpretation. In this study, the antigenic recognition pattern of CAGTA throughout experimental 
invasive candidiasis in a rabbit animal model was determined by means of 2D-PAGE, Western blotting, and tandem mass 
spectrometry (MS/MS). Seven proteins detected by CAGTA were identified as methionine synthase, inositol-3-phosphate 
synthase, enolase 1, alcohol dehydrogenase 1,3-phosphoglycerate kinase, 14-3-3 (Bmh1), and Egd2. To our knowledge, this is 
the first report of antibodies reacting with Bmh1 and Egd2 proteins in an animal model of invasive candidiasis. Although all of 
the antigens were recognized by CAGTA in cell-wall dithiothreitol extracts of both germ tubes and blastospores of C. albicans, 
immunoelectron microscopy study revealed their differential location, as the antigens were exposed on the germ-tube cell-wall 
surface but hidden in the inner layers of the blastospore cell wall. These findings will contribute to developing more sensitive 
diagnostic methods that enable the earlier detection of invasive candidiasis. [Int Microbiol 2014; 17(1):21-29]
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Introduction 
Species of Candida are major fungal pathogens in humans, 
causing a wide variety of surface or mucocutaneous candidia­
ses as well as systemic or invasive candidiasis (IC) in both 
immunocompromised and immunocompetent patients. Al­
though new antifungal agents active against most Candida 
species have recently been introduced, the morbidity and 
mortality rates associated with IC remain high (10–49 %) 
[28]. Between 95 and 97 % of invasive candidiasis are caused 
by five species: C. albicans, C. glabrata, C. parapsilosis, C. tro­
picalis, and C. krusei. Of these, C. albicans is the most pre­
valent species involved in IC, but other species, such as C. kru­
sei, which is intrinsically resistant to azoles, and C. glabrata are 
increasingly being isolated [10]. 
The diagnosis of IC is difficult because there are no spe­
cific signs and it is difficult to distinguish between coloniza­
tion and invasion. Furthermore, the available diagnostic tech­
niques are of low sensitivity and specificity, and the aggres­
sive methods sometimes required to obtain samples are often 
not feasible because of the critical condition of affected pa­
tients [37]. As a result, therapy is often implemented late or 
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not at all, which in part explains the high mortality associated 
with IC [26].
The limitations of traditional microbiological techniques 
have led to the search for new diagnostic methods based on 
the detection of biomarkers, most notably structural and meta­
bolic components of Candida such as mannan, β-1,3-d­
glucan, d­arabinitol, and DNA, as well as Candida antigen 
components and antibodies, but none of these methods are 
conclusive enough for application in clinical practice 
[27,37,40]. García-Ruiz et al. developed an indirect immuno­
fluorescence (IIF) technique that detects specific antibodies to 
antigens located on the surface of the cell wall of C. albicans 
germ tubes (C. albicans germ tube-specific antibodies, CAG­
TA) [8]. Since the mycelial phase of C. albicans is associated 
with tissue invasion, this technique differentiates between 
colonization and invasion. CAGTA detection has proved to be 
useful for the diagnosis of IC in both immunocompetent and 
immunocompromised patients, with a sensitivity and specific­
ity of 79–89 % and 91–100 %, respectively [8,11,41,42]. 
The sensitivity and specificity of the commercial kit Inva­
sive Candidiasis (CAGTA) IFA IgG (Vircell Microbiologists, 
Granada, Spain) in the diagnosis of IC are 84.4 % and 94.7 %, 
respectively [22], and data for its specificity and negative pre­
dictive values have been corroborated in a recent study fo­
cused on the discrimination of deep­seated candidemias from 
transient or catheter­related Candida infections not involving 
deep tissues [20]. León et al. [17] reported that positive CAG­
TA titers combined with positive β-glucan values accurately 
differentiated Candida colonization from IC in intensive care 
unit (ICU) patients with severe abdominal conditions. Also, 
an additional role for CAGTA, as prognostic markers in criti­
cally ill patients in ICUs has been suggested [50,51], based on 
the association of an increase in positive titers of CAGTA 
with a significant decrease in mortality (22.7 % vs. 61.2 % for 
those with negative CAGTA titers), particularly in patients 
undergoing antifungal treatment. The authors of those studies 
therefore have recommended that antifungal therapy be con­
sidered in critically ill patients with increasing CAGTA titers. 
The advantages of the CAGTA method are that it is simple 
and fast, with good sensitivity and specificity. Nonetheless, an 
important limitation is that it has to be evaluated visually by IIF, 
which is a subjective method and thus difficult to standardize. 
In the search for novel biomarkers in the development of 
new diagnostic tools for IC, immunoproteomics has received 
serious consideration [9,25,29,31–33,35]. Serum IgG profiles 
in patients with IC and in healthy controls have been com­
pared in order to identify Candida antigens recognized only 
or mainly by sera from infected patients. This strategy has 
resulted in the identification of a large number of biomarkers 
with potential applications in the early diagnosis of IC 
[9,29,32,33] and in the development of vaccines or immuno­
therapies [7,25,31]. 
In this study an immunoproteomic strategy was used to 
determine the antigen recognition pattern of CAGTA through­
out the course of a C. albicans infection in a rabbit animal 
model. Our results provide a time course and picture of the 
specific antibodies and marker antigens for IC and may serve 
as the basis for the development of new tools in the early and 
objective diagnosis of IC.
Materials and methods 
Strain and culture conditions. All experiments were carried out 
with C. albicans NCPF 3153 (National Collection of Pathogenic Fungi, Bris­
tol, UK). Yeast-phase cells were routinely grown on Sabouraud agar (Difco, 
Sparks, MD, USA) plates at 24 ºC for 48 h. To obtain germ tubes, cells grown 
on Sabouraud agar were inoculated into TC199 medium (Sigma-Aldrich, St. 
Louis, MO, USA) and incubated at 24 ºC with shaking (120 rpm) overnight. 
The resulting blastospores were harvested and then suspended in four vol­
umes of TC199 medium pre-heated to 37 ºC. The germ tubes were collected 
after 4 h of shake-incubation at 37 ºC and 120 rpm. 
Rabbit model of disseminated candidiasis. Two female New 
Zealand White rabbits (Granja Cunícola San Bernardo S.L; Navarra, Spain) 
each weighing approximately 2 kg were injected through the ear marginal 
vein with 2 × 106 blastospores of C. albicans suspended in 0.2 ml of sterile 
saline solution (day 0); inoculation was repeated on days 28, 56, and 84. 
Preimmune sera were withdrawn prior to infection; immune sera were col­
lected through the ear marginal vein every week after the onset of infection. 
Blood samples were left to clot at 4 ºC overnight, and sera were stored at 
–20  ºC until needed.The rabbits were maintained at the animal facilities of 
the University of the Basque Country UPV/EHU (Spain), according to ani­
mal welfare ethics policy. 
Quantification and purification of CAGTA. Serum CAGTA lev­
els were titrated by IIF according to Moragues et al. [22]. The antibodies were 
purified from sera previously adsorbed with an equal volume of a suspension 
of heat­inactivated C. albicans blastospores (1010cell/ml) for 2 h at room tem­
perature, to remove anti­mannan antibodies. Adsorbed sera were centrifuged 
at 2500 rpm for 5 min. The supernatants were mixed with an equal volume of 
a pellet of germ tubes washed with phosphate buffered saline (PBS; Sigma-
Aldrich) and then incubated with gentle agitation at room temperature for 1 h. 
After centrifugation, the samples were washed with PBS and CAGTA bound 
to the mycelial surface were eluted in 5 ml of 2.5 M sodium iodide (Sigma-
Aldrich) in PBS by gentle shaking at room temperature for 1 h. After cen­
trifugation, the supernatants containing the eluted CAGTA were dialyzed 
against PBS (MWCO 12,000–4000 Da; Medicell International, London, UK) and 
concentrated with polyethylene glycol 20,000 (Merck, Hohenbrunn, Germany). 
Two-dimensional polyacrylamide gel electrophoresis (2D-
PAGE) of dithiothreitol (DTT) cell-wall extracts from Can-
dida albicans. Cell­wall proteins of C. albicans NCPF 3153 were ex­
tracted with DTT from germ tubes (DTT-GT) or blastospores (DTT-B), ac­
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cording to Ponton and Jones [38]. Two hundred µg of DTT-extracted cell-
wall proteins were processed for western blotting, and 500 µg for Coomassie 
staining as follows: Cell-wall extracts were suspended in rehydration buffer 
containing 7 M urea, 2 M thiourea, 4 % 3-[(3-cholamidopropyl)dimethyl-
ammonio]-1-propanesulfonate (CHAPS), 20 mM DTT, 0.5 % IPG buffer pH 
4–7 (v/v), and traces of bromophenol blue, and adsorbed onto 11-cm strips 
containing an immobilized pH gradient of 4–7 (IPG; GE Healthcare Bio-
Sciences, Uppsala, Sweden), with active rehydration at 50 V for 12 h at 
20 ºC. Isoelectric focusing was carried out on a Protean IEF cell electropho­
resis unit (Bio-Rad, Hercules, CA, USA) under the following conditions: step 
1, 250 V for 20 min; step 2, ramped to 8000 V over 2.5 h; and step 3, 8000 V 
for a total of 30,000 V/h. After focusing, the IPG strips were equilibrated for 
15 min in a reducing solution of 1 % DTT (w/v) in 75 mM Tris-HCl pH 8.8, 
6 M urea, 30 % glycerol (v/v), 2 % sodium dodecyl sulfate (SDS) (w/v) 
(TUG-SDS) and then in an alkylating solution of 2.5 % iodoacetamide (w/v) 
in TUG-SDS, with gentle shaking. The second dimension was run in a Crite­
rion XT Bis-Tris 4–12 % gel (Bio-Rad) in a Protean II electrophoresis cham­
ber (Bio-Rad) at a constant voltage of 200 V for 55 min. Protein spots were 
stained with the colloidal blue staining kit (Invitrogen, USA) or electroblot­
ted onto a polyvinyl difluoride (PVDF) membrane (Immobilon-P, Millipore, 
Bedford, MA, USA) using a semidry Fast-blot system (Biometra, Germany) 
and transfer buffer (25 mM Tris, 150 mM glycine, and 10 % methanol) at 0.25 
mA/cm2 for 1 h. 
Western blotting. PVDF membranes were incubated with the eluted 
CAGTA in Tris-buffered saline (TBS; 10 mM Tris-HCl, 0.9 % NaCl [w/v], 
pH 7.3) containing 8 % skimmed milk (TBS-M) in a humid chamber at 37 ºC 
for 1 h with gentle shaking. After washing three times with TBS, the mem­
branes were incubated with horseradish peroxidase (HRP)-conjugated anti-
rabbit IgG antibody (Sigma-Aldrich; 1:300 in TBS-M) under the same condi­
tions. After washing with TBS, the membranes were processed with the Im­
mun-Star HRP chemiluminescence kit (Bio-Rad) and the reactions were visu­
alized with the Chemidoc Quantity One system (Bio-Rad). The reactive pro­
teins were excised from parallel gels and identified by tandem mass spec­
trometry (MS/MS). At least two replicates of each sample were obtained.
Mass spectrometry analysis. Selected protein spots were excised 
manually from the gel and subjected to in­gel tryptic digestion according to 
Shevchenko et al.[44], with minor modifications. The gel pieces were swol­
len in digestion buffer (50 mM NH4HCO3 and 12.5 ng/ µl proteomics grade 
trypsin [Roche, Basel, Switzerland]) and the digestion was allowed to pro­
ceed at 37 °C overnight. The supernatant was recovered and peptides were 
extracted twice, first with 25 mM NH4HCO3 and acetonitrile (ACN, Thermo 
Scientific Pierce), and then with 0.1 % trifluoroacetic acid (Thermo Scientific 
Pierce) and ACN. The recovered supernatants and extracted peptides were 
pooled, dried in a SpeedVac, dissolved in 10 µl of 0.1 % formic acid (FA) 
(Thermo Scientific Pierce), and sonicated for 5 min.
MS/MS analysis was performed in a SYNAPT HDMS mass spectrome­
ter (Waters, Milford, MA, USA) interfaced with a nanoAcquity UPLC sys­
tem (Waters). An 8-µl aliquot of each sample was loaded into a Symmetry300 
C18 (180 µm × 20 mm) precolumn (Waters) and washed with 0.1 % FA for 3 
min at a flow rate of 5 µl/min. The precolumn was connected to a BEH130 
C18 column (75 µm x 200 mm; Waters) equilibrated in 3 % ACN and 0.1 % 
FA. Peptides were eluted with a 30-min linear gradient of 3–60 % ACN di­
rectly into a nano­electrospray capillary tip. The capillary voltage was set to 
3500 V and data­dependent MS/MS acquisitions were performed on precur­
sors with charge states of 2, 3, or 4 over a survey m/z range of 350–1990.
Spectra were processed using the Virtual Expert Mass Spectrometrist 
(VEMS) software [21] and searched against the SwissProt database (restrict­
ed to “other fungi”) using Mascot (Matrix Science, London, UK). Protein 
identification was based on the following variables: carbamidomethylation of 
cysteines as fixed modification, oxidation of methionines as variable modifi­
cation, 50­ppm peptide mass tolerance, 0.1­Da fragment mass tolerance, and 
1 missed cleavage.
Electron microscopy and immunocytochemistry. Candida al­
bicans germ tubes or blastospores were washed in Sorenson’s buffer [0.133 
M Na2HPO4, 0.133 M KH2PO4 [4:1 v/v], pH 7.4], treated with fixing solution 
(0.5 % glutaraldehyde, 4 % formaldehyde in Sorenson’s buffer) at 4 °C for 24 h, 
and washed with 88 mM sucrose in Sorenson’s buffer. The cells were dehy­
drated using graded concentrations of acetone, embedded in Spurr resin (low-
viscosity embedding medium Spurr’s kit, Electron Microscopy Sciences, 
Hatfield, PA, USA), and polymerized at 56 ºC for 2 days. Sections 50- to 
100­nm­thick were deposited on 200­mesh nickel grids coated with Formvar 
(Electron Microscopy Sciences) and blocked with blocking solution (10 % 
inactivated goat serum, 0.02 % sodium azide, 0.1 % Tween-20 in PBS, pH 8.2) 
at room temperature for 1 h with gentle shaking in a humid chamber. The 
samples were then incubated with the eluted CAGTA in the incubation solu­
tion (1 % inactivated goat serum, 1 % BSA, 0.02 % sodium azide, 0.1 % 
Tween-20 in PBS, pH 8.2) for 2 h under the same conditions. After washing 
with incubation solution, the samples were incubated with anti-rabbit IgG 
antibody labeled with 10-nm diameter colloidal gold (Sigma-Aldrich; 1:10 in 
incubation solution) under the same conditions. Finally, the samples were 
washed with blocking solution and distilled water, stained with 2 % uranyl 
acetate and lead citrate, and observed in a transmission electron microscope 
Philips EM208S. Negative controls without primary antibody were per­
formed, and samples were obtained from two independent experiments.
 
Results 
Fungal infection of rabbits with Candida albicans. The in­
jection of four doses of 2 × 106 blastospores of C. albicans 
NCPF 3153 produced a disseminated fungal infection in the 
two rabbits, and their immune systems developed antibodies 
(CAGTA) that recognized antigens on the surface of C. albi­
cans germ tubes, as determined by IIF (Fig. 1). CAGTA titers 
were estimated for each serum sample collected during the 
course of the experiment, and rabbits 1 and 2 showed a similar 
trend in their humoral immune responses to IC (Fig. 2). The 
levels of CAGTA rose moderately after the first injection but 
increased significantly after the second and third injections, 
reaching peak titers (1/640 and 1/1280) on day 72. Although 
differing in extent, the CAGTA titers for the two rabbits tended 
to stabilize by the end of the third round of infection (Fig. 2). 
Antigens recognized by CAGTA. Since CAGTA serve 
as markers of invasive Candida infection, we identified the re­
acting antigens in a DTT cell-wall extract of C. albicans germ 
tubes (DTT-GT) separated by 2D-PAGE. The reproducibility of 
the gels allowed a comparison of the Coomassie­stained refer­
ence protein map (Fig. 3A) with the spots reacting with the 
CAGTA by immunoblotting (Fig. 3C), and thereby the identifi­
cation of the corresponding proteins by MS/MS analysis.  
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When analyzed by Western blotting, pre-immune sera 
(day 0) adsorbed with C. albicans blastospores were not reac­
tive with C. albicans DTT-GT proteins. However, the eluted 
CAGTA purified from immune sera obtained on days 3, 17, 
37, and 58 after the initial infection recognized several protein 
spots on the DTT-GT bidimensional map. Seven proteins 
were identified by MS/MS: methionine synthase (Met6), ino­
sitol-3-phosphate synthase (Ino1), enolase 1 (Eno1), alcohol 
dehydrogenase 1 (Adh1), 3-phosphoglycerate kinase (Pgk1), 
14-3-3 (or Bmh1), and nascent polypeptide-associated com­
plex, α subunit (or Egd2) (Fig. 3A,C). CAGTA reactivity was 
highly similar for the two rabbits although the intensities of 
the reactions oscillated over the course of the infection (Table 1). 
Antigens Eno1 and Ino1 showed a strong reactivity that began 
at the early stages of infection (Table 1) and remained stable 
over time. Met6 and Adh1 displayed an intermittent reactivity 
with either of the rabbit antisera (Table 1). CAGTA exhibited 
strong reactivity against the 14­3­3 protein in the sera of both 
rabbits three days after the initial infection (Table 1), even though 
CAGTA were not appreciable by IIF at that time. This reactiv­
In
t M
ic
ro
bi
ol
Fig. 1. Reaction of serum CAGTA from a rabbit with disseminated candidia­
sis with the cell­wall surface of Candida albicans germ tubes, as evidenced 
by indirect immunofluorescence [22]. The germ-tube surfaces stain brightly 
(light green in the color version of the image) after their reaction with a sec­
ondary FITC-conjugated anti-rabbit IgG antibody (Sigma); the blastospores 
are red following contrast staining with Evan’s blue.
Fig. 2. Change over time of the serum CAGTA response of two rabbits infected with Candida albicans NCPF 3153. 
Arrows indicate the time (days 0, 28, 56, and 84) at which the rabbits were infected intravenously with 2 × 106 blasto­
spores in saline.
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ity gradually diminished over time but recovered after the 
second inoculation with C. albicans. A reaction with Egd2 
was not observed until day 37 (Table 1), after which the reac­
tivity remained strong with rabbit 2 sera but gradually faded 
in the sera of rabbit 1. Similarly, CAGTA reactivity against 
Pgk1 was weaker in sera from rabbit 1 (Table 1). In addition, as 
shown in the 2D profiles stained with Coomassie blue (Fig. 
3A), most antigens had several isoforms such that their reac­
tivity with CAGTA in the sera of both rabbits was rather het­
erogeneous. 
In a different approach to characterize the antigens react­
ing with CAGTA, the 2D-PAGE protein pattern displayed by 
the DTT cell-wall extracts of C. albicans blastospores was 
compared with that of the germ tubes. The images from Coo­
massie stained 2D­gels were very similar for most of the pro­
teins, although some of the bands differed in their relative 
concentrations and/or electrophoretic mobility (Fig. 3A,B). 
However, using CAGTA purified from the 58-day serum 
of rabbit 2, the main antigens recognized in the DTT­B 
extract were the same as those identified in the DTT-GT 
extract (Fig. 3C,D).
Location of antigens recognized by CAGTA. Im­
munoelectron microscopy, used to locate the identified antigens 
in the C. albicans cell wall, revealed that the CAGTA reacted 
with superficial elements of the germ-tube cell walls (Fig. 4A), 
although reactive components were also present in the inner 
layers. By contrast, CAGTA only reacted with compounds lo­
cated in the inner layers of the blastospore cell wall (Fig. 4B). 
Discussion 
Because of the commensal nature of C. albicans, one of the 
challenges of the serological diagnosis of IC has been to dif­
ferentiate between colonized and infected patients. The detec­
tion of CAGTA solves this diagnostic problem since the anti­
bodies recognize specific antigens on the surface of C. albi­
cans germ tubes, the morphological phase associated with 
invasion. However, immunofluorescence-based analysis re­
quires subjective interpretation of the results, ruling out auto­
mation of the process and thus its standardization. In this 
study, we set out to characterize the antigen recognition pat­
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Fig. 3. Two-dimensional electrophoresis of DTT cell-wall extracts of germ tubes and blastopores of Candida albicans NCPF 3153. (A) 
Germ tubes (DTT-GT). (B) Blastopores (DTT-B). Gels were stained with the colloidal blue staining kit (Invitrogen). Immunoblot of DTT-
GT (C) and DTT-B (D) extracts assayed with CAGTA eluted from the serum of rabbit 2 on day 58 of the IC model of infection.
Int. MIcrobIol. Vol. 17, 2014 Sáez-RoSón et al.26
tern of CAGTA over the duration of IC using a rabbit animal 
model. The recognition in IC patients of at least a subset of 
these antigens by one or more CAGTA may provide the basis 
for the development of more sensitive and specific diagnostic 
techniques for IC, as reported by Clancy et al. [3].
Western blot analysis of C. albicans DTT-GT extracts 
separated by 2D-PAGE identified Met6, Ino1, Eno1, Adh1, 
Pgk1, 14–3–3 (Bmh1), and Egd2 as the major proteins recog­
nized by the CAGTA of rabbits with IC. Although these pro­
teins are involved in cellular processes carried out in the cyto­
plasm, they have also been detected in the cell wall of C. albi­
cans blastospores [2,19,23,43,48] and mycelia [6,19,36,47,48]. 
Several of these proteins are involved in cellular metabolism, 
such as Eno1 and Pgk1, which are glycolytic enzymes. Eno1 
has also been described as an allergen [12], while Pgk1 par­
ticipates in the biogenesis and degradation of the C. albicans 
cell wall [1]. Adh1 is involved in glucose fermentation, by 
reducing acetaldehyde to ethanol, and is also an allergen. 
Note that these three proteins bind human plasminogen, gen­
erating the proteolytic enzyme plasmin, which could increase 
the capacity of C. albicans for tissue invasiveness and necro­
sis [5,13]. Ino1 catalyzes the conversion of glucose-6-phos­
phate to inositol-1-phosphate, the first step in the production 
of inositol­containing components such as phospholipids, 
which are essential for cell-membrane lipid bilayers [15]. 
Met6 is involved in the biosynthesis of methionine during C. 
albicans morphogenesis and is essential for growth, by limit­
ing the toxicity of homocysteine [45]. 
Table 1. Major cell-wall proteins in DTT extracts of Candida albicans germ tubes reacting with CAGTA raised in two rabbits with experimental 
disseminated candidiasis
               CAGTA reactivitye (days of infection)
      Rabbit 1    Rabbit 2  
Protein name (Accesion No.)a Spot No.b Mr (kDa)c pId 0 3 17 37 58 0 3 17 37 58
Methionine synthase (P82610) 1–4 85.8 5.44 – – ++ – +++ – – ++ – ++
Inositol­3­phosphate synthase 
(P42800)
5–7 57.8 5.35 – – +++ +++ ++ – – +++ ++ ++
Enolase-1 (P30575) 8–12 47.2 5.54 – – +++ +++ +++ – + ++ ++ +++
Alcohol dehydrogenase 1 
(P43067)
13–15 37.2 6.02 – – ++ – ++ – – + – ++
Phosphoglicerate kinase 1  
(P46273)
16–17 45.3 6.07 – – – + + – + ++ + +++
Bmh1 (O42766) 18 29.6 4.75 – +++ – +++ +++ – +++ + ++ +++
Nascent polypeptide­associated 
complex subunit alpha 
(Q5ANP2)
19–21 19.5 4.7 – – – ++ – – – – +++ +++
                              CAGTA titerf 0 0 10 80 320 0 0 20 80 160
aProtein name and accession number according to the UniProtKB database. bSpot numbers as indicated in the gel shown in Figure 3A.
cProtein molecular weight as shown in the SwissProt database. dTheoretical isoelectric point as shown in the SwissProt database.
eCAGTA reactivity levels (+++, very strong; ++, strong; +, mild; –, no reactivity). fCAGTA titer (inverse) of sera evaluated by IIF.
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Bmh1 and Egd2 are also involved in other cellular pro­
cesses. Bmh1 is required for both the vegetative growth and 
the filamentation of C. albicans. In addition, it participates in 
processes such as the cellular response to stimuli, chlamydo­
spore formation, pathogenesis, the regulation of carbohydrate 
metabolism, and signal transduction [4,14,24,49]. Therefore, 
this protein is likely to play a key role in colonization and in­
vasion, by coordinating the necessary regulatory systems. 
Egd2 is the α subunit of the ribosomal nascent polypeptide-
associated complex, which consists of Egd1 and Egd2. It par­
ticipates in the transport of both cytoplasmic and mitochon­
drial proteins, binding to emerging polypeptides and thereby 
ensuring their proper orientation.
All of the above proteins have been described in both blas­
tospores and mycelia of C. albicans, but quantitative studies 
have shown differences in their expression depending on the 
morphology of the fungus. Pitarch et al. [36] have found that, 
among others, Pgk1, Eno1, Adh1, and Ino1 are overexpressed 
after the induction of C. albicans germination. Martínez-Go­
mariz et al. [19] have added Met6 to this group of proteins. 
While Ebanks et al. [6] have also reported the expression of 
Adh1 protein in the mycelial phase, they found greater 
amounts of Egd2 and Eno1 in the yeast phase. In our study the 
protein map of DTT-GT cell-wall extract separated by 2D-
PAGE also differed to some extent from that of DTT-B ex­
tracts. However, CAGTA eluted from germ tubes of C. albi­
cans reacted mainly with the same antigens in the two ex­
tracts. Since in the IIF assay CAGTA reacted only with com­
pounds of the cell surface of germ tubes, we asked whether 
the cellular location of the antigens depended on the morphol­
ogy of C. albicans. Immunoelectron microscopy showed that 
CAGTA reacted with antigens that were mainly located on the 
outer layers of germ­tube cell walls, whereas in blastospores 
reactivity was in the inner layers of the cell wall. The morpho­
logical dependence of the position of some antigens in the C. al­
bicans cell-wall structure has been reported by Pontón et al. 
[39], who described four types of antigens in the C. albicans 
cell wall based on their differential reactivity with several 
monoclonal antibodies. According to that system, the CAGTA 
antigens described in our study belong to type II, since they 
were located on the surface of the germ­tube cell wall and in 
the inner layers of the blastospore cell wall. 
The location of at least some of the proteins on the outer 
germ­tube surface is in agreement with the development of 
CAGTA as a specific response of the host immune system 
during the invasive process. Our observations are consistent 
with those of other immunoproteomic studies that have attri­
buted antigenic characteristics to most of the proteins identifi­
ed using these antibodies, both in murine models of infection 
[30,46] and in patients with IC [9,25,29,31,32,34,35]. The im­
munogenicity of these proteins has allowed the development 
of ELISA tests to detect specific antibodies of diagnostic util­
ity, with satisfactory results reported for recombinant Eno1 
[16,18,32], Met6, and Pgk1 [3,33].
 To the best of our knowledge, ours is the first study to 
identify Bmh1 and Egd2 in a study characterizing the CAGTA 
response in an animal infection model. In addition to this, 
CAGTA of both rabbits reacted with Bmh1 at a very early 
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Fig. 4. Transmission electron microscopy images of the cell wall of Candida albicans NCPF 3153, showing the reaction of CAGTA purified from 
the serum of a rabbit infected with this fungal strain. Note that the colloidal gold particles are mainly located in the outermost cell­wall layers of the 
germ tubes (A), and in the inner cell-wall layers of blastospores (B). Arrows indicate the different positions of the colloidal gold particles.
Int. MIcrobIol. Vol. 17, 2014 Sáez-RoSón et al.28
stage of infection, only 3 days after the first inoculation, be­
fore CAGTA were detectable by IIF. The apparent absence of 
this reactivity in the preimmune sera may reflect previous sen­
sitization to low levels of this protein, given the commensal 
nature of C. albicans in the yeast­phase morphology. Since 
Bmh1 belongs to a family of conserved regulatory proteins 
expressed in all eukaryotic cells, such that the rabbits may 
have been previously sensitized, the paradoxical behavior of 
CAGTA could be indicative of a quick response to the expo­
sure of this antigen on the surface of the C. albicans germ 
tubes at the onset of fungal invasion. Because Bmh1 is in­
volved in the filamentation process [14] and reacts with CAG­
TA of infected rabbits, the detection in serum of this protein 
and/or specific antibodies against it may allow its use as an 
early marker of IC. Further studies would be essential to con­
firm this relationship and whether it also pertains to IC in hu­
mans.
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